(Q34553766)

3 August 2017

Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants (English)

1 reference

3 August 2017

0 references

angiogenesis inhibitor

1 reference

Yu Cao

1

1 reference

3 August 2017

Zhao-Di Fu

2

1 reference

3 August 2017

Fang Wang

3

1 reference

3 August 2017

Hong-Yan Liu

4

1 reference

3 August 2017

Rui Han

5

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

Journal of Asian Natural Products Research

3 August 2017

1 reference

3 August 2017

7

1 reference

3 August 2017

3

1 reference

3 August 2017

205-213

1 reference

Angiogenesis in cancer and other diseases

3 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F10286020410001690190

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020410001690190

Assays for angiogenesis: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020410001690190

Mechanisms and future directions for angiogenesis-based cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020410001690190

Mechanisms of cancer chemoprevention by soy isoflavone genistein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020410001690190

Green tea constituent epigallocatechin-3-gallate inhibits angiogenic differentiation of human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020410001690190

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020410001690190

Resveratrol and quercetin inhibit angiogenesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020410001690190

Thiolutin, an inhibitor of HUVEC adhesion to vitronectin, reduces paxillin in HUVECs and suppresses tumor cell-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020410001690190

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020410001690190

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020410001690190

Activation of pro-(matrix metalloproteinase-2) (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein endothelial cells and generates a distinct 63 kDa active species

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020410001690190

Matrix metalloproteinases and the development of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020410001690190

Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020410001690190

Regulation of vascular growth and regression by matrix metalloproteinases in the rat aorta model of angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020410001690190

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020410001690190

10.1080/10286020410001690190

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference